Yichun Qian
Department Of Head And Neck Surgery, No. 42 Baiziting, Xuanwu District
Nanjing, 210009, China
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Prognostic factors in patients with persistent/recurrent differentiated thyroid carcinoma after comprehensive treatment
Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Published: March 18, 2022
Long Non-coding RNA RUNDC3A-AS1 Promotes Lung Metastasis of Thyroid Cancer via Targeting the miR-182-5p/ADAM9.
Journal: Frontiers in cell and developmental biology
Published: January 06, 2021
Prognostic factors and the effect of radioiodine on patients with locally advanced differentiated thyroid cancer.
Journal: Annals of translational medicine
Published: September 21, 2020
Correction to: Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 03, 2020
Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 30, 2019
Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 25, 2018
Circulating Long Noncoding RNAs as Biomarkers for Predicting Head and Neck Squamous Cell Carcinoma.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: February 04, 2018
miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10.
miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10.
Journal: International journal of molecular medicine
Published: December 01, 2017
MiR-206 inhibits Head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 14, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026